Short answer
UTAH MEDICAL PRODUCTS INC (UTMD) filed an 8-K current report with the SEC on November 3, 2026 reporting Item 8.01 (Other Events), Item 99.1 (), Item EX-99.1 (Exhibit EX-99.1). Quarterly cash dividend increased to $0.315 per share.
UTAH MEDICAL PRODUCTS INC 8-K event analysis
AI summary of each reported item and its exhibits
Item 8.01 · Other Events
- Quarterly cash dividend increased to $0.315 per share
- Payment scheduled for January 5, 2027
- Shareholder record date: December 17, 2026
- Dividend increase signals greater cash-return commitment to shareholders
Item 99.1 ·
- Filing contains only the 8-K signature block, with no substantive operating, financial, or strategic disclosure
- CEO Kevin L. Cornwell signed the report on November 3, 2026
Item EX-99.1 · Exhibit EX-99.1
- Quarterly dividend increased 1.6% to $0.315 per share
- Payment scheduled January 5, 2027, for shareholders of record December 17, 2026
- Dividend increase signals continued commitment to returning cash to shareholders
- Recurring payout raises ongoing cash-flow obligations, though no broader capital-allocation changes announced
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other UTAH MEDICAL PRODUCTS INC 8-K filings
Get the next UTMD 8-K as it lands
Follow UTMD for push alerts, or ask the research agent what this filing means.